Profile
Michel Dreano is the founder of Sonnet BioTherapeutics CH SA and Remedys Foundation.
Prior to this, he worked as CFO, Director & Chief Business Officer at RELIEF THERAPEUTICS Holding SA from 2017 to 2019 and as a Manager-Project & Alliance at Serono International SA. Dr. Dreano holds a doctorate degree from L'Université de Bourgogne and Université Paris Diderot-Paris 7.
Michel Dreano active positions
| Companies | Position | Start |
|---|---|---|
Remedys Foundation | Founder | - |
Former positions of Michel Dreano
| Companies | Position | End |
|---|---|---|
| MINDMAZE THERAPEUTICS HOLDING SA | Director of Finance/CFO | 26/04/2019 |
Serono International SA | Corporate Officer/Principal | - |
Sonnet BioTherapeutics CH SA
Sonnet BioTherapeutics CH SA Pharmaceuticals: MajorHealth Technology Manufactures drugs for peripheral neuropathies | Founder | - |
Training of Michel Dreano
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
L'Université de Bourgogne
L'Université de Bourgogne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université Paris Diderot-Paris 7
Université Paris Diderot-Paris 7 Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Serono International SA | |
Sonnet BioTherapeutics CH SA
Sonnet BioTherapeutics CH SA Pharmaceuticals: MajorHealth Technology Manufactures drugs for peripheral neuropathies | Health Technology |
RELIEF THERAPEUTICS Holding SA
RELIEF THERAPEUTICS Holding SA Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of biopharmaceutical products for respiratory diseases | Health Technology |
Remedys Foundation |
- Stock Market
- Insiders
- Michel Dreano
















